메뉴 건너뛰기




Volumn 64, Issue 9, 2003, Pages 1057-1064

Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: A preliminary double-blind, placebo-controlled study

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; CITALOPRAM; FLUOXETINE; MIRTAZAPINE; MODAFINIL; NEFAZODONE; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

EID: 0141828593     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v64n0911     Document Type: Article
Times cited : (177)

References (62)
  • 1
    • 0015095265 scopus 로고
    • Depressive disease: Classification and clinical characteristics
    • Baker M, Dorzab J, Winokur G, et al. Depressive disease: classification and clinical characteristics. Compr Psychiatry 1971;12:354-365
    • (1971) Compr Psychiatry , vol.12 , pp. 354-365
    • Baker, M.1    Dorzab, J.2    Winokur, G.3
  • 2
    • 0031946526 scopus 로고    scopus 로고
    • How to improve recognition and diagnosis of depressive syndromes using international diagnostic criteria
    • Maurice-Tison S, Verdoux H, Gay B, et al. How to improve recognition and diagnosis of depressive syndromes using international diagnostic criteria. B J Gen Pract 1998;48:1245-1246
    • (1998) B J Gen Pract , vol.48 , pp. 1245-1246
    • Maurice-Tison, S.1    Verdoux, H.2    Gay, B.3
  • 3
    • 0032796231 scopus 로고    scopus 로고
    • DEPRES II (Depression Research in European Society II): A patient survey of the symptoms, disability and current management of depression in the community
    • Tylee A, Gastpar M, Lepine J-P, et al. DEPRES II (Depression Research in European Society II): a patient survey of the symptoms, disability and current management of depression in the community. Int Clin Psychopharmacol 1999;14:139-151
    • (1999) Int Clin Psychopharmacol , vol.14 , pp. 139-151
    • Tylee, A.1    Gastpar, M.2    Lepine, J.-P.3
  • 4
    • 0033659328 scopus 로고    scopus 로고
    • Adverse events and treatment discontinuation in clinical trials of fluoxetine in major depressive disorder: An updated meta-analysis
    • Beasley CM Jr, Koke SC, Nilsson ME, et al. Adverse events and treatment discontinuation in clinical trials of fluoxetine in major depressive disorder: an updated meta-analysis. Clin Ther 2000;22:1319-1330
    • (2000) Clin Ther , vol.22 , pp. 1319-1330
    • Beasley C.M., Jr.1    Koke, S.C.2    Nilsson, M.E.3
  • 5
    • 0034009877 scopus 로고    scopus 로고
    • Clinical issues in long-term treatment with antidepressants
    • Zajecka JM. Clinical issues in long-term treatment with antidepressants. J Clin Psychiatry 2000;61(suppl 2):20-25
    • (2000) J Clin Psychiatry , vol.61 , Issue.SUPPL. 2 , pp. 20-25
    • Zajecka, J.M.1
  • 6
    • 0032908414 scopus 로고    scopus 로고
    • Residual symptoms in depressed patients who respond acutely to fluoxetine
    • Nierenberg AA, Keefe BR, Leslie VC, et al. Residual symptoms in depressed patients who respond acutely to fluoxetine. J Clin Psychiatry 1999;60:221-225
    • (1999) J Clin Psychiatry , vol.60 , pp. 221-225
    • Nierenberg, A.A.1    Keefe, B.R.2    Leslie, V.C.3
  • 7
    • 0028827547 scopus 로고
    • Residual symptoms after partial remission: An important outcome in depression
    • Paykel ES, Ramana R, Cooper Z, et al. Residual symptoms after partial remission: an important outcome in depression. Psychol Med 1995;25: 1171-1180
    • (1995) Psychol Med , vol.25 , pp. 1171-1180
    • Paykel, E.S.1    Ramana, R.2    Cooper, Z.3
  • 8
    • 0032171096 scopus 로고    scopus 로고
    • Major depressive disorder: A prospective study of residual subthreshold depressive symptoms as predictors of rapid relapse
    • Judd LL, Akiskal HS, Maser JD, et al. Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictors of rapid relapse. J Affect Disord 1998;50:97-108
    • (1998) J Affect Disord , vol.50 , pp. 97-108
    • Judd, L.L.1    Akiskal, H.S.2    Maser, J.D.3
  • 9
    • 0032161791 scopus 로고    scopus 로고
    • Relapse of depression in primary care: Rate and clinical predictors
    • Lin EHB, Katon WJ, VanKorff M, et al. Relapse of depression in primary care: rate and clinical predictors. Arch Fam Med 1998;7:443-449
    • (1998) Arch Fam Med , vol.7 , pp. 443-449
    • Lin, E.H.B.1    Katon, W.J.2    VanKorff, M.3
  • 10
    • 0026806719 scopus 로고
    • Treatments of depression and the functional capacity to work
    • Mintz J, Mintz LI, Arruda MJ, et al. Treatments of depression and the functional capacity to work. Arch Gen Psychiatry 1992;49:761-768
    • (1992) Arch Gen Psychiatry , vol.49 , pp. 761-768
    • Mintz, J.1    Mintz, L.I.2    Arruda, M.J.3
  • 11
    • 0031761583 scopus 로고    scopus 로고
    • The treatment of chronic depression, pt 3: Psychosocial functioning before and after treatment with sertraline or imipramine
    • Miller IW, Keitner GI, Schatzberg AF, et al. The treatment of chronic depression, pt 3: psychosocial functioning before and after treatment with sertraline or imipramine. J Clin Psychiatry 1998;59:608-619
    • (1998) J Clin Psychiatry , vol.59 , pp. 608-619
    • Miller, I.W.1    Keitner, G.I.2    Schatzberg, A.F.3
  • 12
    • 0034050052 scopus 로고    scopus 로고
    • Augmentation strategies in depression 2000
    • Nelson JC. Augmentation strategies in depression 2000. J Clin Psychiatry 2000;61(suppl 2):13-19
    • (2000) J Clin Psychiatry , vol.61 , Issue.SUPPL. 2 , pp. 13-19
    • Nelson, J.C.1
  • 13
    • 0019471639 scopus 로고
    • Lithium induces rapid relief of depression in tricyclic antidepressant drug nonresponders
    • deMontigny C, Grunberg F, Mayer A, et al. Lithium induces rapid relief of depression in tricyclic antidepressant drug nonresponders. Br J Psychiatry 1981;138:252-256
    • (1981) Br J Psychiatry , vol.138 , pp. 252-256
    • DeMontigny, C.1    Grunberg, F.2    Mayer, A.3
  • 14
    • 0021047672 scopus 로고
    • Lithium carbonate augmentation of antidepressant treatment: An effective prescription for treatment-refractory depression
    • Heninger GR, Charney DS, Sternberg DR. Lithium carbonate augmentation of antidepressant treatment: an effective prescription for treatment-refractory depression. Arch Gen Psychiatry 1983;40:1335-1342
    • (1983) Arch Gen Psychiatry , vol.40 , pp. 1335-1342
    • Heninger, G.R.1    Charney, D.S.2    Sternberg, D.R.3
  • 15
    • 0024420894 scopus 로고
    • Treatment of endogenous depressions resistant to tricyclic antidepressants or related drugs by lithium addition: Results of a placebo-controlled double-blind study
    • Schopf J, Baumann P, Lemarchand T, et al. Treatment of endogenous depressions resistant to tricyclic antidepressants or related drugs by lithium addition: results of a placebo-controlled double-blind study. Pharmacopsychiatry 1989;22:183-187
    • (1989) Pharmacopsychiatry , vol.22 , pp. 183-187
    • Schopf, J.1    Baumann, P.2    Lemarchand, T.3
  • 16
    • 0027225549 scopus 로고
    • A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression
    • Joffe RT, Singer W, Levitt AJ, et al. A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression. Arch Gen Psychiatry 1993;50:387-393
    • (1993) Arch Gen Psychiatry , vol.50 , pp. 387-393
    • Joffe, R.T.1    Singer, W.2    Levitt, A.J.3
  • 17
    • 0027324914 scopus 로고
    • Lithium augmentation therapy in tricyclic-resistant depression: A controlled trial using lithium in low and normal doses
    • Stein G, Bernadt M. Lithium augmentation therapy in tricyclic-resistant depression: a controlled trial using lithium in low and normal doses. Br J Psychiatry 1993;162:634-640
    • (1993) Br J Psychiatry , vol.162 , pp. 634-640
    • Stein, G.1    Bernadt, M.2
  • 18
    • 0028873941 scopus 로고
    • Placebo-controlled trial of lithium augmentation of fluoxetine and lofepramine
    • Katona CLE, Abou-Saleh MT, Harrison DA, et al. Placebo-controlled trial of lithium augmentation of fluoxetine and lofepramine. Br J Psychiatry 1995;166:80-86
    • (1995) Br J Psychiatry , vol.166 , pp. 80-86
    • Katona, C.L.E.1    Abou-Saleh, M.T.2    Harrison, D.A.3
  • 19
    • 9344237128 scopus 로고    scopus 로고
    • A double-blind, placebo-controlled study of citalopram with and without lithium in the treatment of therapy-resistant depressive patients: A clinical pharmacokinetic, and pharmacogenetic investigation
    • Bauman P, Nil R, Souche A, et al. A double-blind, placebo-controlled study of citalopram with and without lithium in the treatment of therapy-resistant depressive patients: a clinical pharmacokinetic, and pharmacogenetic investigation. J Clin Psychopharmacol 1996;16:307-314
    • (1996) J Clin Psychopharmacol , vol.16 , pp. 307-314
    • Bauman, P.1    Nil, R.2    Souche, A.3
  • 20
    • 0030982240 scopus 로고    scopus 로고
    • Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant monotherapy
    • Bodkin JA, Lasser RA, Wines JD Jr, et al. Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant monotherapy. J Clin Psychiatry 1997;58:137-145
    • (1997) J Clin Psychiatry , vol.58 , pp. 137-145
    • Bodkin, J.A.1    Lasser, R.A.2    Wines J.D., Jr.3
  • 21
    • 0031832763 scopus 로고    scopus 로고
    • Use of buproprion with SRIs and venlafaxine
    • Spier SA. Use of buproprion with SRIs and venlafaxine. Depress Anxiety 1998;7:73-75
    • (1998) Depress Anxiety , vol.7 , pp. 73-75
    • Spier, S.A.1
  • 22
    • 0032977425 scopus 로고    scopus 로고
    • Combination treatment with venlafaxine and bupropion
    • Kirsch MA, Louie AK. Combination treatment with venlafaxine and bupropion [letter]. Am J Psychiatry 1999;156:494
    • (1999) Am J Psychiatry , vol.156 , pp. 494
    • Kirsch, M.A.1    Louie, A.K.2
  • 23
    • 0037310632 scopus 로고    scopus 로고
    • A prospective trial of bupropion augmentation of partial and non-responders to serotonergic antidepressants
    • DeBattista C, Solvason HB, Poirier J, et al. A prospective trial of bupropion augmentation of partial and non-responders to serotonergic antidepressants. J Clin Psychopharmacol 2003;23:27-30
    • (2003) J Clin Psychopharmacol , vol.23 , pp. 27-30
    • DeBattista, C.1    Solvason, H.B.2    Poirier, J.3
  • 24
    • 0020076151 scopus 로고
    • Potentiation of antidepressant effects by L-triiodothyronine in tricyclic nonresponders
    • Goodwin FK, Prange AJ, Post R, et al. Potentiation of antidepressant effects by L-triiodothyronine in tricyclic nonresponders. Am J Psychiatry 1982;139:34-38
    • (1982) Am J Psychiatry , vol.139 , pp. 34-38
    • Goodwin, F.K.1    Prange, A.J.2    Post, R.3
  • 25
    • 0024442135 scopus 로고
    • Treatment of imipramine-resistant recurrent depression, 1: An open clinical trial of adjunctive L-triiodothyronine
    • Thase ME, Kupfer DJ, Jarrett DB. Treatment of imipramine-resistant recurrent depression, 1: an open clinical trial of adjunctive L-triiodothyronine. J Clin Psychiatry 1989;50:385-388
    • (1989) J Clin Psychiatry , vol.50 , pp. 385-388
    • Thase, M.E.1    Kupfer, D.J.2    Jarrett, D.B.3
  • 26
    • 0025374125 scopus 로고
    • A comparison of triiodothyronine and thyroxine in the potentiation of tricyclic antidepressants
    • Joffe RT, Singer W. A comparison of triiodothyronine and thyroxine in the potentiation of tricyclic antidepressants. Psychiatry Res 1990;32: 241-251
    • (1990) Psychiatry Res , vol.32 , pp. 241-251
    • Joffe, R.T.1    Singer, W.2
  • 27
    • 0026503565 scopus 로고
    • Triiodothyronine potentiation of fluoxetine in depressed patients
    • Joffe RT. Triiodothyronine potentiation of fluoxetine in depressed patients. Can J Psychiatry 1992;37:48-50
    • (1992) Can J Psychiatry , vol.37 , pp. 48-50
    • Joffe, R.T.1
  • 28
    • 0032910369 scopus 로고    scopus 로고
    • Risperidone augmentation of selective serotonin reuptake inhibitors in major depression
    • Ostroff RB, Nelson JC. Risperidone augmentation of selective serotonin reuptake inhibitors in major depression. J Clin Psychiatry 1999;60: 256-259
    • (1999) J Clin Psychiatry , vol.60 , pp. 256-259
    • Ostroff, R.B.1    Nelson, J.C.2
  • 29
    • 0035169876 scopus 로고    scopus 로고
    • A novel augmentation strategy for treating resistant major depression
    • Shelton RC, Tollefson GD, Tohen M, et al. A novel augmentation strategy for treating resistant major depression. Am J Psychiatry 2001;158:131-134
    • (2001) Am J Psychiatry , vol.158 , pp. 131-134
    • Shelton, R.C.1    Tollefson, G.D.2    Tohen, M.3
  • 30
    • 0015074126 scopus 로고
    • A potential clinical use of methylphenidate with tricyclic antidepressants
    • Wharton RN, Perel JM, Dayton PG, et al. A potential clinical use of methylphenidate with tricyclic antidepressants. Am J Psychiatry 1971; 127:55-61
    • (1971) Am J Psychiatry , vol.127 , pp. 55-61
    • Wharton, R.N.1    Perel, J.M.2    Dayton, P.G.3
  • 31
    • 0021945989 scopus 로고
    • Combined MAOI, TCA, and direct stimulant therapy of treatment-resistant depression
    • Feighner JP, Herbstein J, Damlouji N. Combined MAOI, TCA, and direct stimulant therapy of treatment-resistant depression. J Clin Psychiatry 1985;46:206-209
    • (1985) J Clin Psychiatry , vol.46 , pp. 206-209
    • Feighner, J.P.1    Herbstein, J.2    Damlouji, N.3
  • 32
    • 0024380272 scopus 로고
    • Treatment of a refractory depression with a combination of fluoxetine and d-amphetamine
    • Linet LS. Treatment of a refractory depression with a combination of fluoxetine and d-amphetamine [letter]. Am J Psychiatry 1989;146: 803-904
    • (1989) Am J Psychiatry , vol.146 , pp. 803-904
    • Linet, L.S.1
  • 33
    • 0026167906 scopus 로고
    • Combination of fluoxetine with pemoline in the treatment of major depressive disorder
    • Metz A, Shader RI. Combination of fluoxetine with pemoline in the treatment of major depressive disorder. Int Clin Psychopharmacol 1991; 6:93-96
    • (1991) Int Clin Psychopharmacol , vol.6 , pp. 93-96
    • Metz, A.1    Shader, R.I.2
  • 34
    • 0025860023 scopus 로고
    • CNS stimulant potentiation of monamine oxidase inhibitors in treatment-refractory depression
    • Fawcett J, Kravitz HM, Zajecka JM, et al. CNS stimulant potentiation of monamine oxidase inhibitors in treatment-refractory depression. J Clin Psychopharmacol 1991;11:127-132
    • (1991) J Clin Psychopharmacol , vol.11 , pp. 127-132
    • Fawcett, J.1    Kravitz, H.M.2    Zajecka, J.M.3
  • 35
    • 0030022134 scopus 로고    scopus 로고
    • Methylphenidate augmentation of serotonin selective reuptake inhibitors: A case series
    • Stoll AL, Pillay SS, Diamond L, et al. Methylphenidate augmentation of serotonin selective reuptake inhibitors: a case series. J Clin Psychiatry 1996;57:72-76
    • (1996) J Clin Psychiatry , vol.57 , pp. 72-76
    • Stoll, A.L.1    Pillay, S.S.2    Diamond, L.3
  • 36
    • 0031803048 scopus 로고    scopus 로고
    • Venlafaxine augmentation with methylphenidate for treatment-refractory depression: A case report
    • Bader GM, Hawley JM, Short DD. Venlafaxine augmentation with methylphenidate for treatment-refractory depression: a case report [letter]. J Clin Psychopharmacol 1998;18:255-256
    • (1998) J Clin Psychopharmacol , vol.18 , pp. 255-256
    • Bader, G.M.1    Hawley, J.M.2    Short, D.D.3
  • 37
    • 0035233551 scopus 로고    scopus 로고
    • Augmentation and combination strategies in treatment-resistant depression
    • Fava M. Augmentation and combination strategies in treatment-resistant depression. J Clin Psychiatry 2001;62(suppl 18):4-11
    • (2001) J Clin Psychiatry , vol.62 , Issue.SUPPL. 18 , pp. 4-11
    • Fava, M.1
  • 38
    • 0030816557 scopus 로고    scopus 로고
    • Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy
    • Broughton RJ, Fleming JA, George CG, et al. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy. Neurology 1997;49:444-451
    • (1997) Neurology , vol.49 , pp. 444-451
    • Broughton, R.J.1    Fleming, J.A.2    George, C.G.3
  • 39
    • 2642638767 scopus 로고    scopus 로고
    • Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy
    • US Modafinil in Narcolepsy Multicenter Study Group. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. Ann Neurol 1998;43:88-97
    • (1998) Ann Neurol , vol.43 , pp. 88-97
  • 40
    • 0342545934 scopus 로고    scopus 로고
    • Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy
    • US Modafinil in Narcolepsy Multicenter Study Group. Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy. Neurology 2000;54:1166-1175
    • (2000) Neurology , vol.54 , pp. 1166-1175
  • 41
    • 0031057460 scopus 로고    scopus 로고
    • Modafinil in obstructive sleep apnea-hypopnea syndrome: A pilot study in 6 patients
    • Arnulf I, Homeyer P, Garma L, et al. Modafinil in obstructive sleep apnea-hypopnea syndrome: a pilot study in 6 patients. Respiration 1997; 64:159-161
    • (1997) Respiration , vol.64 , pp. 159-161
    • Arnulf, I.1    Homeyer, P.2    Garma, L.3
  • 42
    • 0037759333 scopus 로고    scopus 로고
    • Short term effects of modafinil on sleepiness in patients with sleep disordered breathing
    • Cassel W, Heitmann J, Kemeny C, et al. Short term effects of modafinil on sleepiness in patients with sleep disordered breathing [abstract]. J Sleep Res 1998;7(suppl 2):83
    • (1998) J Sleep Res , vol.7 , Issue.SUPPL. 2 , pp. 83
    • Cassel, W.1    Heitmann, J.2    Kemeny, C.3
  • 43
    • 0035509118 scopus 로고    scopus 로고
    • Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea
    • Pack AI, Black JE, Schwartz JRL, et al. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea. Am J Respir Crit Care Med 2001;164:1675-1681
    • (2001) Am J Respir Crit Care Med , vol.164 , pp. 1675-1681
    • Pack, A.I.1    Black, J.E.2    Schwartz, J.R.L.3
  • 44
    • 0001797882 scopus 로고    scopus 로고
    • Fatigue in multiple sclerosis; evaluation and a new pharmacological approach
    • Terzoudi M, Gavrielidou P, Heilakos G, et al. Fatigue in multiple sclerosis; evaluation and a new pharmacological approach. Neurology 2000;54(suppl 3):A61-A62
    • (2000) Neurology , vol.54 , Issue.SUPPL. 3
    • Terzoudi, M.1    Gavrielidou, P.2    Heilakos, G.3
  • 45
    • 0036152780 scopus 로고    scopus 로고
    • Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: A two centre phase 2 study
    • Rammohan KW, Rosenberg JH, Lynn DJ, et al. Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study [abstract]. J Neurol Neurosurg Psychiatry 2002;72:179-183
    • (2002) J Neurol Neurosurg Psychiatry , vol.72 , pp. 179-183
    • Rammohan, K.W.1    Rosenberg, J.H.2    Lynn, D.J.3
  • 46
    • 0034078972 scopus 로고    scopus 로고
    • Modafinil augmentation of antidepressant treatment in depression
    • Menza MA, Kaufman KR, Castellanos A. Modafinil augmentation of antidepressant treatment in depression. J Clin Psychiatry 2000;61: 378-381
    • (2000) J Clin Psychiatry , vol.61 , pp. 378-381
    • Menza, M.A.1    Kaufman, K.R.2    Castellanos, A.3
  • 48
    • 0004237991 scopus 로고
    • Tampa, Fla.: University of South Florida, Institute for Research in Psychiatry, and Paris, France: INSERM-Hopital de la Salpetriere
    • Sheehan DV, Lecrubier Y, et al. Mini-International Neuropsychiatric Interview (MINI). Tampa, Fla.: University of South Florida, Institute for Research in Psychiatry, and Paris, France: INSERM-Hopital de la Salpetriere; 1994
    • (1994) Mini-International Neuropsychiatric Interview (MINI)
    • Sheehan, D.V.1    Lecrubier, Y.2
  • 49
    • 0024420189 scopus 로고
    • The Fatigue Severity Scale: Applications to patients with multiple sclerosis and systemic lupus erythematosus
    • Krupp LB, LaRocca NG, Muir-Nash J, et al. The Fatigue Severity Scale: applications to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989;46:1121-1123
    • (1989) Arch Neurol , vol.46 , pp. 1121-1123
    • Krupp, L.B.1    LaRocca, N.G.2    Muir-Nash, J.3
  • 50
    • 0026333617 scopus 로고
    • A new method for measuring daytime sleepiness: The Epworth Sleepiness Scale
    • Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 1991;14:540-545
    • (1991) Sleep , vol.14 , pp. 540-545
    • Johns, M.W.1
  • 52
    • 0014186152 scopus 로고
    • Development of a rating scale for primary depressive illness
    • Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278-296
    • (1967) Br J Soc Clin Psychol , vol.6 , pp. 278-296
    • Hamilton, M.1
  • 53
    • 0003412410 scopus 로고
    • US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, Md: National Institute of Mental Health
    • Guy W. ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, Md: National Institute of Mental Health; 1976:218-222
    • (1976) ECDEU Assessment Manual for Psychopharmacology , pp. 218-222
    • Guy, W.1
  • 54
    • 0027569430 scopus 로고
    • The MOS 36-item short-form health survey (SF-36), 2: Psychometric and clinical test of validity in measuring physical and mental health constructs
    • McHorney CA, Ware JE, Raczek AE. The MOS 36-item short-form health survey (SF-36), 2: psychometric and clinical test of validity in measuring physical and mental health constructs. Med Care 1993;31: 247-263
    • (1993) Med Care , vol.31 , pp. 247-263
    • McHorney, C.A.1    Ware, J.E.2    Raczek, A.E.3
  • 55
    • 0028120266 scopus 로고
    • The MOS 36-item short form health survey (SF-36), 3: Test of data quality, scaling assumptions, and reliability across diverse patient groups
    • McHorney CA, Ware JE, Lu JFR, et al. The MOS 36-item short form health survey (SF-36), 3: test of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994;32:40-66
    • (1994) Med Care , vol.32 , pp. 40-66
    • McHorney, C.A.1    Ware, J.E.2    Lu, J.F.R.3
  • 56
    • 0028156958 scopus 로고
    • Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States
    • Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry 1994;51:2-22
    • (1994) Arch Gen Psychiatry , vol.51 , pp. 2-22
    • Kessler, R.C.1    McGonagle, K.A.2    Zhao, S.3
  • 57
    • 0023769647 scopus 로고
    • Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil
    • Bastuji H, Jouvet M. Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil. Prog Neuropsych Biol Psychiatry 1988;12: 695-700
    • (1988) Prog Neuropsych Biol Psychiatry , vol.12 , pp. 695-700
    • Bastuji, H.1    Jouvet, M.2
  • 58
    • 0001140216 scopus 로고    scopus 로고
    • Effect of Provigil (modafinil) on the quality of life and mood of patients who previously received unsatisfactory treatment with dextroamphetamine, methylphenidate, or pemoline for excessive daytime sleepiness associated with narcolepsy
    • Feldman NT, Schwartz JRL, Harsh J. Effect of Provigil (modafinil) on the quality of life and mood of patients who previously received unsatisfactory treatment with dextroamphetamine, methylphenidate, or pemoline for excessive daytime sleepiness associated with narcolepsy [abstract]. Sleep 2000;23(suppl 2):A307
    • (2000) Sleep , vol.23 , Issue.SUPPL. 2
    • Feldman, N.T.1    Schwartz, J.R.L.2    Harsh, J.3
  • 59
    • 0033568724 scopus 로고    scopus 로고
    • Health-related quality of life effects of modafinil for treatment of narcolepsy
    • Beusterien KM, Rogers AE, Walsleben JA, et al. Health-related quality of life effects of modafinil for treatment of narcolepsy. Sleep 1999;22: 757-765
    • (1999) Sleep , vol.22 , pp. 757-765
    • Beusterien, K.M.1    Rogers, A.E.2    Walsleben, J.A.3
  • 60
    • 0001140215 scopus 로고    scopus 로고
    • Long-term efficacy, safety, and dosing profile of Provigil (modafinil) for the treatment of excessive daytime sleepiness associated with narcolepsy
    • Ristanovic R, Hayduk, R, Mitler MM. Long-term efficacy, safety, and dosing profile of Provigil (modafinil) for the treatment of excessive daytime sleepiness associated with narcolepsy [abstract]. Sleep 2000(suppl 2):A304
    • (2000) Sleep , Issue.SUPPL. 2
    • Ristanovic, R.1    Hayduk, R.2    Mitler, M.M.3
  • 61
    • 0001609188 scopus 로고    scopus 로고
    • Long-term efficacy and safety of modafinil (Provigil) for the treatment of excessive daytime sleepiness associated with narcolepsy
    • Mitler MM, Harsh J, Hirshkowitz M, et al. Long-term efficacy and safety of modafinil (Provigil) for the treatment of excessive daytime sleepiness associated with narcolepsy. Sleep Med 2000;1:231-243
    • (2000) Sleep Med , vol.1 , pp. 231-243
    • Mitler, M.M.1    Harsh, J.2    Hirshkowitz, M.3
  • 62
    • 0012170492 scopus 로고    scopus 로고
    • Efficacy and safety profiles of Provigil (modafinil) maintained during long-term (40 and 88 weeks) treatment of excessive daytime sleepiness associated with narcolepsy
    • Emsellem HA and the US Modafinil Study Group. Efficacy and safety profiles of Provigil (modafinil) maintained during long-term (40 and 88 weeks) treatment of excessive daytime sleepiness associated with narcolepsy [abstract]. Neurology 2000;54(suppl 3):A29-A30
    • (2000) Neurology , vol.54 , Issue.SUPPL. 3
    • Emsellem, H.A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.